Your session is about to expire
← Back to Search
Proton Beam Radiation for Rhabdomyosarcoma
Study Summary
This trial is testing whether proton beam radiation, which affects less healthy tissue than photon beam radiation, can reduce side effects from radiation treatment for rhabdomyosarcoma.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2017 Phase 1 & 2 trial • 50 Patients • NCT00438256Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am receiving a widely accepted chemotherapy treatment.I am aged 2-10 with a specific type of cancer, allowing for metastatic disease.My radiation therapy is scheduled as per the approved plan, within 35 days of my last chemo or surgery.I have health conditions that make radiation unsafe for me.I have undergone radiation therapy before.I have been newly diagnosed with rhabdomyosarcoma.I am receiving a widely accepted chemotherapy treatment.I am 21 years old or younger.
- Group 1: Proton Beam Radiation
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Does Proton Beam Radiation have FDA approval?
"Proton Beam Radiation is deemed as a 2 in terms of safety. Phase 2 trials only have data supporting the safety of the treatment and not its efficacy."
How many study participants are currently enrolled?
"That is correct. The listing for this trial on clinicaltrials.gov shows that it is currently open for recruitment and has been since October 1st, 2004. 110 people are needed to complete the study at 3 different locations."
Are we still enrolling people for this clinical trial?
"According to the latest information available on clinicaltrials.gov, this trial is looking for candidates. The listing was originally posted on October 1st, 2004 and was last updated September 30th, 2021."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Share this study with friends
Copy Link
Messenger